PATENT CLAIM ANALYSIS

Application Number: 15760971
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "064000"]

Abstract:
Disclosed herein are compounds comprising dicarba-closo-dodecaborane. The compounds can be, for example, estrogen receptor beta (ERβ) agonists. In some examples, the compounds can be selective ERβ agonists. Also provided herein are methods of treating, preventing, or ameliorating cancer in a subject, suppressing tumor growth in a subject, treating an inflammatory disease in a subject, treating a neurodegenerative disease in a subject, treating a psychotropic disorder in a subject, or a combination thereof by administering to a subject a therapeutically effective amount of one or more of the compounds or compositions described herein, or a pharmaceutically acceptable salt thereof.

Claim (Index 50):
The compound of any of  claims 1 - 49 , wherein the compound has an EC 50  of 6 nM or less at estrogen receptor beta (ER\u03b2).

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.88525
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13439991', '14352210', '15453953', '14090158', '10594483']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7571439778882951
- 35 USC 102 Novelty (BERT): 0.5145165611311909
- Combined Prediction Score: 0.7328812362125847
- Mean Citation Score: 268.98001800000003
- Max Citation Score: 282.6429
- Similarity Product: 188.7603028446436

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test